AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11783243 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite salviae dropping pill (CSDP)
Number of subjects: 70
Study 11783243 — intervention group
Group type: COMPARATOR
Intervention: Isosorbide dinitrate (ID)
Number of subjects: 70
Study 8676423 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmenting DO2 with fluids, blood, and vasopressors
Number of subjects: 15
Study 1930035 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 minute oxytocin dose escalation
Number of subjects: 224
Study 1930035 — intervention group
Group type: COMPARATOR
Intervention: 30 minute oxytocin dose escalation
Number of subjects: 224
Study 3883697 — intervention group
Group type: EXPERIMENTAL
Intervention: Alaproclate 200 mg twice daily
Number of subjects: 40
Study 3883697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31874882 — intervention group
Group type: EXPERIMENTAL
Intervention: Periacetabular osteotomy (PAO) followed by usual care and progressive resistance training (PRT) for 8 months after 4 months of usual care
Number of subjects: 96
Study 31874882 — intervention group
Group type: COMPARATOR
Intervention: Progressive resistance training (PRT) only for 12 months
Number of subjects: 96
Study 30177338 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) of CTO (n=77)
Number of subjects: 158
Study 30177338 — intervention group
Group type: COMPARATOR
Intervention: No-CTO PCI (n=81)
Number of subjects: 158
Study 27428186 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment with methotrexate, leflunomide, and hydroxychloroquine for up to 36 weeks
Number of subjects: 346
Study 27428186 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering DMARDs treatment after achieving remission (DAS28 ≤ 2.6) and low HAQ (≤ 0.5)
Number of subjects: 346
Study 27428186 — intervention group
Group type: COMPARATOR
Intervention: Leflunomide monotherapy
Number of subjects: 346
Study 25414593 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined psoas compartment-sciatic nerve block (PCSNB) using 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine and iliac crest block with 5 mL of the same solution.
Number of subjects: 70
Study 25414593 — intervention group
Group type: COMPARATOR
Intervention: Continuous spinal anaesthesia (CSA) using 2.5 mg of isobaric bupivacaine 0.5%, with additional doses if sensory block did not reach T12.
Number of subjects: 70
Study 22692125 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive static stretching (PSS)
Number of subjects: 17
Study 22692125 — intervention group
Group type: COMPARATOR
Intervention: Active dynamic warm-up (AD)
Number of subjects: 17
Study 21193005 — intervention group
Group type: EXPERIMENTAL
Intervention: Test product
Number of subjects: 14
Study 21193005 — intervention group
Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 14
Study 18399947 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 4 mg twice daily for 3 days
Number of subjects: 15
Study 18399947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 17176790 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.1%
Number of subjects: 28
Study 17176790 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 28
Study 14522414 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril pre-treatment for 5 days
Number of subjects: 30
Study 14522414 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 2 hours before LPS infusion
Number of subjects: 30
Study 14522414 — intervention group
Group type: COMPARATOR
Intervention: Placebo pre-treatment for 5 days
Number of subjects: 30
Study 10951609 — intervention group
Group type: EXPERIMENTAL
Intervention: Agoraphobic patients
Number of subjects: 34
Study 10951609 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 34
Study 8776360 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid (betamethasone dipropionate) + tretinoin 0.1%
Number of subjects: 20
Study 8776360 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid (betamethasone dipropionate)
Number of subjects: 20
Study 1623802 — intervention group
Group type: EXPERIMENTAL
Intervention: T + E (Terbutaline + Enalapril 10 mg)
Number of subjects: 20
Study 1623802 — intervention group
Group type: EXPERIMENTAL
Intervention: T + S (Terbutaline + Spironolactone 100 mg)
Number of subjects: 20
Study 1623802 — intervention group
Group type: COMPARATOR
Intervention: T (Terbutaline alone)
Number of subjects: 20
Study 6098505 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg bid)
Number of subjects: 4
Study 6098505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 31491444 — intervention group
Group type: EXPERIMENTAL
Intervention: N35 (35 min nap opportunity)
Number of subjects: 20
Study 31491444 — intervention group
Group type: EXPERIMENTAL
Intervention: N45 (45 min nap opportunity)
Number of subjects: 20
Study 31491444 — intervention group
Group type: EXPERIMENTAL
Intervention: N25 (25 min nap opportunity)
Number of subjects: 20
Study 31491444 — intervention group
Group type: COMPARATOR
Intervention: N0 (no nap opportunity)
Number of subjects: 20
Study 30007061 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-controlled pressure pain threshold as test-stimulus and tourniquet cuff as conditioning stimulus
Number of subjects: 26
Study 30007061 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual pressure algometry and cold water immersion
Number of subjects: 26
Study 30007061 — intervention group
Group type: EXPERIMENTAL
Intervention: Various CPM protocols
Number of subjects: 26
Study 26755688 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg)
Number of subjects: 14
Study 26755688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 26755688 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone
Number of subjects: 14
Study 24002924 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on training for the Lachman test (15 minutes with lightly embalmed cadaver)
Number of subjects: 0
Study 24002924 — intervention group
Group type: COMPARATOR
Intervention: Lecture-only training on knee anatomy and Lachman test
Number of subjects: 0
Study 22005892 — intervention group
Group type: EXPERIMENTAL
Intervention: LITA in patients with intermediate-grade stenosis
Number of subjects: 142
Study 22005892 — intervention group
Group type: COMPARATOR
Intervention: LITA in patients with high-grade stenosis
Number of subjects: 142
Study 22005892 — intervention group
Group type: EXPERIMENTAL
Intervention: LITA lumen area in patients with intermediate-grade stenosis
Number of subjects: 142
Study 22005892 — intervention group
Group type: COMPARATOR
Intervention: LITA lumen area in patients with high-grade stenosis
Number of subjects: 142
Study 19450896 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose interferon-alpha (IFN-alpha)
Number of subjects: 21
Study 17822189 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjunctival-limbal autografting
Number of subjects: 60
Study 17822189 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C 0.02% for two minutes
Number of subjects: 60
Study 16280432 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose solution (300 mL)
Number of subjects: 5
Study 16280432 — intervention group
Group type: COMPARATOR
Intervention: Water (control, 300 mL)
Number of subjects: 5
Study 16280432 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame solution (300 mL)
Number of subjects: 5
Study 16280432 — intervention group
Group type: EXPERIMENTAL
Intervention: Maltodextrin solution (300 mL)
Number of subjects: 5
Study 12228789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg
Number of subjects: 184
Study 12228789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 20 mg
Number of subjects: 184
Study 12228789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study 12228789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine (both doses)
Number of subjects: 184
Study 12228789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 184
Study 10321487 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit processing in neglect patient (JS) using a flanker task with coloured letters.
Number of subjects: 1
Study 10321487 — intervention group
Group type: COMPARATOR
Intervention: Controls in the flanker task.
Number of subjects: 1
Study 8708979 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid Gaviscon (20 mL single dose)
Number of subjects: 12
Study 8708979 — intervention group
Group type: EXPERIMENTAL
Intervention: Algitec Suspension (20 mL single dose)
Number of subjects: 12
Study 8708979 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 12
Study 8708979 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid Gaviscon
Number of subjects: 12
Study 8708979 — intervention group
Group type: EXPERIMENTAL
Intervention: Algitec Suspension
Number of subjects: 12
Study 2196360 — intervention group
Group type: EXPERIMENTAL
Intervention: APDT vaccine
Number of subjects: 75
Study 2196360 — intervention group
Group type: COMPARATOR
Intervention: DTP vaccine
Number of subjects: 75
Study 424686 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejuno-ileal bypass operation
Number of subjects: 5
Study 30620643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast bolus delivery (30 s using Animas IR2020 pump)
Number of subjects: 20
Study 28145409 — intervention group
Group type: EXPERIMENTAL
Intervention: Active dTMS (20 sessions over the left dorsolateral prefrontal cortex, H1-coil, 55 18 Hz 2 s 120% MT trains)
Number of subjects: 50
Study 28145409 — intervention group
Group type: COMPARATOR
Intervention: Sham dTMS
Number of subjects: 50
Study 28145409 — intervention group
Group type: EXPERIMENTAL
Intervention: Active dTMS
Number of subjects: 50
Study 26225442 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervision program (announcements of inspections, site visits, individualized reports)
Number of subjects: 356
Study 26225442 — intervention group
Group type: COMPARATOR
Intervention: Control care groups
Number of subjects: 356
Study 26225442 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervision program
Number of subjects: 356
Study 23359664 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement System for Adherence (MESA)
Number of subjects: 76
Study 23359664 — intervention group
Group type: COMPARATOR
Intervention: Active nutrition and physical activity control
Number of subjects: 76
Study 21987967 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-assisted relaxation training (using a video clip of virtual reality relaxing scenes)
Number of subjects: 60
Study 20205027 — intervention group
Group type: EXPERIMENTAL
Intervention: Persuasive message advocating smoking cessation
Number of subjects: 254
Study 20205027 — intervention group
Group type: COMPARATOR
Intervention: No-information control condition
Number of subjects: 254
Study 20205027 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-ups at 2 and 8 months
Number of subjects: 254
Study 20205027 — intervention group
Group type: EXPERIMENTAL
Intervention: Point prevalence seven-day quitting
Number of subjects: 254
Study 16603797 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaeger Masterlab bodyplethysmograph, Pneumoscreen pneumotachograph, Masterscreen CS‐FRC, Masterlab CompactTransfer
Number of subjects: 59
Study 16603797 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed flow generator
Number of subjects: 59
Study 16603797 — intervention group
Group type: EXPERIMENTAL
Intervention: Wave form generator
Number of subjects: 59
Study 16603797 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo study
Number of subjects: 59
Study 12677622 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg of IV lidocaine (group L)
Number of subjects: 40
Study 12677622 — intervention group
Group type: COMPARATOR
Intervention: 0.1 mL/kg of IV isotonic saline (group C)
Number of subjects: 40
Study 11149431 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 120
Study 11149431 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 120
Study 9175666 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal serum beta-HCG level in women with fetal growth retardation (n = 31)
Number of subjects: 57
Study 9175666 — intervention group
Group type: COMPARATOR
Intervention: Maternal serum beta-HCG level in women with normal growth (n = 26)
Number of subjects: 57
Study 9175666 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between maternal serum beta-HCG level and umbilical artery systolic/diastolic ratio
Number of subjects: 57
Study 8400327 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of tumour cyclic AMP binding proteins (> 8 pmol/mg cytosol protein)
Number of subjects: 0
Study 2418713 — intervention group
Group type: EXPERIMENTAL
Intervention: Formaldehyde modified ragweed allergen (allergoid) 10,710 PNU pre-seasonally
Number of subjects: 20
Study 2418713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2418713 — intervention group
Group type: EXPERIMENTAL
Intervention: Formaldehyde modified ragweed allergen (allergoid)
Number of subjects: 20
Study 29669667 — intervention group
Group type: EXPERIMENTAL
Intervention: GSP301 (olopatadine 665 μg - mometasone 50 μg)
Number of subjects: 30
Study 29669667 — intervention group
Group type: EXPERIMENTAL
Intervention: OLO-sponsor (olopatadine 665 μg)
Number of subjects: 30
Study 29669667 — intervention group
Group type: EXPERIMENTAL
Intervention: OLO (FDA approved olopatadine 665 μg)
Number of subjects: 30
Study 29669667 — intervention group
Group type: COMPARATOR
Intervention: GSP301
Number of subjects: 30
Study 29669667 — intervention group
Group type: COMPARATOR
Intervention: OLO-sponsor
Number of subjects: 30
Study 29669667 — intervention group
Group type: COMPARATOR
Intervention: OLO
Number of subjects: 30
Study 27010995 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting on stability balls for 90 minutes/day, 5 days/week for 8 weeks
Number of subjects: 90
Study 27010995 — intervention group
Group type: COMPARATOR
Intervention: Control group sat on their usual chair for 8 weeks
Number of subjects: 90
Study 27010995 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting on stability balls
Number of subjects: 90
Study 27010995 — intervention group
Group type: EXPERIMENTAL
Intervention: Ball-sitting
Number of subjects: 90
Study 24913451 — intervention group
Group type: EXPERIMENTAL
Intervention: Version 2 (V2) of the e-learning resource
Number of subjects: 0
Study 24913451 — intervention group
Group type: COMPARATOR
Intervention: Version 1 (V1) of the e-learning resource
Number of subjects: 0
Study 24913451 — intervention group
Group type: EXPERIMENTAL
Intervention: Both versions (V1 and V2)
Number of subjects: 0
Study 22823966 — intervention group
Group type: EXPERIMENTAL
Intervention: High-repetitive single limb exercise (HRSLE) training with elastic bands, 60 minutes, three times/week for 8 weeks combined with four sessions of 60 minutes patient education.
Number of subjects: 0
Study 22823966 — intervention group
Group type: COMPARATOR
Intervention: Patient education alone.
Number of subjects: 0
Study 20413741 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking with body weight support (up to 30 minutes per day)
Number of subjects: 126
Study 20413741 — intervention group
Group type: COMPARATOR
Intervention: Overground walking (up to 30 minutes per day)
Number of subjects: 126
Study 18483167 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential AA supplementation (AA group, n = 7)
Number of subjects: 31
Study 18483167 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with AA given 3 h after training (RT group, n = 12)
Number of subjects: 31
Study 18483167 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with AA given 5 min before training (AART group, n = 12)
Number of subjects: 31
Study 18483167 — intervention group
Group type: COMPARATOR
Intervention: AA group (control)
Number of subjects: 31
Study 18483167 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance training with AA supplementation (RT and AART groups)
Number of subjects: 31
Study 15587882 — intervention group
Group type: EXPERIMENTAL
Intervention: New priority X-ray method for examining the large bowel (one-stage double contrasting)
Number of subjects: 150
Study 15587882 — intervention group
Group type: COMPARATOR
Intervention: Traditional irrigoscopy and classical double contrasting
Number of subjects: 150
Study 11434120 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative epidural blockade
Number of subjects: 100
Study 9209769 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic cluster headache patients
Number of subjects: 27
Study 7811150 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of delayed action mexiletine
Number of subjects: 77
Study 3658285 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-mg 17 beta-estradiol pellets
Number of subjects: 12
Study 3658285 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-mg 17 beta-estradiol pellets
Number of subjects: 12
Study 3658285 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-mg and 50-mg 17 beta-estradiol pellets
Number of subjects: 12
Study 31317627 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mL of 75% oral sucrose (n = 20)
Number of subjects: 40
Study 31317627 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterilised water) (n = 20)
Number of subjects: 40
Study 29068099 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclosporin 50 mg/mL solution for injection administered subcutaneously for 60 days, with initial doses ranging from 2.5 mg/kg once daily to every other day, and 5 mg/kg once daily to every other day.
Number of subjects: 11
Study 27484224 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost (1 ng/kg/min) infusion for 48 hours
Number of subjects: 40
Study 27484224 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) infusion
Number of subjects: 40
Study 27484224 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost with blood pressure target of 65 mmHg
Number of subjects: 40
Study 27484224 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost with blood pressure target of 75 mmHg
Number of subjects: 40
Study 27484224 — intervention group
Group type: COMPARATOR
Intervention: Placebo with blood pressure target of 65 mmHg
Number of subjects: 40
Study 27484224 — intervention group
Group type: COMPARATOR
Intervention: Placebo with blood pressure target of 75 mmHg
Number of subjects: 40
Study 27484224 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost infusion
Number of subjects: 40
Study 27484224 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 40
Study 25400947 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg orally every 12 hours for at least 2 days
Number of subjects: 600
Study 25400947 — intervention group
Group type: COMPARATOR
Intervention: Magnesium sulfate 4 grams intravenously
Number of subjects: 600
Study 22494852 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental retrieval of exposure session
Number of subjects: 72
Study 22494852 — intervention group
Group type: COMPARATOR
Intervention: Control condition (recall of everyday activities)
Number of subjects: 72
Study 21168619 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose of cyclosporine (blood cyclosporine C2, 800-1500 ng/mL) with MMF and standard doses of corticosteroids.
Number of subjects: 80
Study 21168619 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of cyclosporine (blood cyclosporine C2, 450-800 ng/mL) with MMF plus low doses of corticosteroids after induction 48 hours before surgery.
Number of subjects: 80
Study 21168619 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group I)
Number of subjects: 80
Study 21168619 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group II)
Number of subjects: 80
Study 18212330 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills-demands compatibility manipulation
Number of subjects: 0
Study 18212330 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 16725396 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-vitamin-D3-fortified milk (1000 mg/day calcium and 800 IU/day vitamin D3)
Number of subjects: 111
Study 12555214 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboembolic events (TE)
Number of subjects: 183
Study 12555214 — intervention group
Group type: COMPARATOR
Intervention: No thromboembolic events (Control)
Number of subjects: 183
Study 12555214 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary TE
Number of subjects: 183
Study 12555214 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent TE
Number of subjects: 183
Study 12555214 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary TE
Number of subjects: 183
Study 12555214 — intervention group
Group type: EXPERIMENTAL
Intervention: TE patients
Number of subjects: 183
Study 11040177 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (0.75‐1 mg x kg(‐1) x day(‐1))
Number of subjects: 25
Study 11040177 — intervention group
Group type: COMPARATOR
Intervention: Heparin (continuous infusion)
Number of subjects: 25
Study 9222576 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-session, learner-centred, small group CME program
Number of subjects: 15
Study 9222576 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 control subjects)
Number of subjects: 15
Study 1350734 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyanhydrides as bioerodible polymers for drug delivery applications
Number of subjects: 0
Study 1350734 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyanhydride-based drug delivery treatment
Number of subjects: 0
Study 2981616 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonantradol (1 mg every 4 hours)
Number of subjects: 26
Study 2981616 — intervention group
Group type: COMPARATOR
Intervention: Delta-9-tetrahydrocannabinol (THC) (15 mg every 4 hours)
Number of subjects: 26
Study 2981616 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonantradol
Number of subjects: 26
Study 2981616 — intervention group
Group type: COMPARATOR
Intervention: Delta-9-tetrahydrocannabinol (THC)
Number of subjects: 26
Study 30736764 — intervention group
Group type: EXPERIMENTAL
Intervention: CST with specific, structured and behavior‐orientated feedback (CST-behav)
Number of subjects: 66
Study 30736764 — intervention group
Group type: COMPARATOR
Intervention: General, experience‐orientated feedback (CST-exp)
Number of subjects: 66
Study 29568986 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG)
Number of subjects: 103